Metabolic tumor volume is an independent prognostic factor in patients treated definitively for nonsmall-cell lung cancer

Clinical Lung Cancer

Volumn 13, Issue 1, 2012, Pages 52-58

  Lee, Percy ^a,b   Bazan, Jose G ^a   Lavori, Philip W ^a   Weerasuriya, Dilani K ^a   Quon, Andrew ^a   Le, Quynh Thu ^a   Wakelee, Heather A ^c   Graves, Edward E ^a   Loo, Billy W ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC TUMOR VOLUME; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; REVIEW; TUMOR VOLUME;

EID: 84855662230     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2011.05.001     Document Type: Article

References (21)

1. A. Jemal, R. Siegel, E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. D.M. Parkin, F. Bray, J. Ferlay Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108 (Pubitemid 40372904)
3. M.D. Brundage, D. Davies, W.J. Mackillop Prognostic factors in non-small cell lung cancer: a decade of progress Chest 122 2002 1037 1057
4. P. Goldstraw, J. Crowley, K. Chansky The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours J Thorac Oncol 2 2007 706 714 (Pubitemid 47357522)
5. M. Paesmans, T. Berghmans, M. Dusart Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project J Thorac Oncol 5 2010 612 619
6. H. Vesselle, J.D. Freeman, L. Wiens Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role Clin Cancer Res 13 2007 3255 3263 (Pubitemid 46944910)
7. P. Lee, D.K. Weerasuriya, P.W. Lavori Metabolic tumor burden predicts for disease progression and death in lung cancer Int J Radiat Oncol Biol Phys 69 2007 328 333 (Pubitemid 47380105)
8. E.E. Graves, A. Quon, B.W. Loo RT-Image: an open-source tool for investigating PET in radiation oncology Technol Cancer Res Treat 6 2007 111 121
9. R Development Core Team R: A language and environment for statistical computing 2006 R Foundation for Statistical Computing Vienna
10. P.M. Grambsch, T.M. Therneau Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 1994 515 526
11. D.L. Ball, R. Fisher, B. Burmeister Stage is not a reliable indicator of tumor volume in non-small cell lung cancer: a preliminary analysis of the Trans-Tasman Radiation Oncology Group 99-05 database J Thorac Oncol 1 2006 667 672 (Pubitemid 47163954)
12. J.D. Bradley, N. Ieumwananonthachai, J.A. Purdy Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma Int J Radiat Oncol Biol Phys 52 2002 49 57 (Pubitemid 34041565)
13. C. Dehing-Oberije, D. De Ruysscher, H. van der Weide Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy Int J Radiat Oncol Biol Phys 70 2008 1039 1044 (Pubitemid 351308062)
14. K.J. Biehl, F.M. Kong, F. Dehdashti 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? J Nucl Med 47 2006 1808 1812 (Pubitemid 47545003)
15. T.H. La, E.J. Filion, B.B. Turnbull Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer Int J Radiat Oncol Biol Phys 74 2009 1335 1341
16. M.K. Chung, H.-S. Jeong, S.G. Park Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer Clin Cancer Res 15 2009 5861 5868
17. M.K. Chung, H.-S. Jeong, Y.-I. Son Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue Ann Surg Oncol 16 2009 3111 3117
18. P. Xie, J.B. Yue, H.X. Zhao Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma J Cancer Res Clin Oncol 136 2010 883 889
19. Y.M. Seol, B.R. Kwon, M.K. Song Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy Acta Oncol 49 2010 201 208
20. S.H. Hyun, J.Y. Choi, Y.M. Shim Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma Ann Surg Oncol 17 2010 115 122
21. 18F-Fluorodeoxyglucose positron emission tomography imaging in assessing patients before and after treatment for locally advanced non-small cell lung cancer (ACRIN 6668/RTOG 0235) Vol 2010 http://clinicaltrials.gov/ct2/show/ NCT00083083 Accessed: May 1, 2010